Dual Cdc7 Cdk9 kinase inhibitor, PHA-767491, targets both quiescent and proliferating CLL cells

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputAbstract
Volume8
Publication statusPublished - 1 Nov 2010

Cite this